General Info
Location: 29 Newbury Street
Country: United States of America
Industries: biotechnology, biopharmaceutical, healthcare, genomics, immunology, cardiometabolic diseases, neurodegenerative diseases, autoimmune diseases, neuropsychiatry
Investment Regions:
Investment Stages: seed
Website: http://www.thirdrockventures.com/
vc
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Third Rock Ventures has multiple portfolio/press updates in 2025 including ARTBIO (Series B announced July 29, 2025) and Tango Therapeutics (multiple 2025 entries, e.g., June 27, 2025). The most recent investment-related company announcement is from July and later portfolio news through October 2025 show activity; the most recent direct investment/financing announcement found is ARTBIO Series B on July 29, 2025, which is within 3 months of the calculation date (less than 3 months). Therefore classify as very-active.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Abbie …
Partner
Andrew …
Senior Associate
Robert …
Partner
Cary …
Partner
Charles …
Partner
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Third Rock Ventures, LLC

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
